Network origin in Roberto Zoncu first degree
Entity | Entity type | Industry | |
---|---|---|---|
Frontier Medicines Corp.
Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA.
10
| Holding Company | Pharmaceuticals: Major | 10 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Roberto Zoncu via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
ARIAD PHARMACEUTICALS, INC. | Biotechnology | Founder | |
Idun Pharmaceuticals, Inc.
Idun Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Idun Pharmaceuticals, Inc. is a biopharmaceutical company that engages in the discovery and development of human therapeutics to control apoptosis. The company was founded by John C. Reed, Robert H. Horvitz, and Lawrence C. Fritz in March 1993 and is headquartered in San Diego, CA. | Medical Specialties | Director/Board Member | |
SYNDAX PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
AGIOS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Consultant / Advisor | |
University of Virginia | College/University | Doctorate Degree | |
MPM BioImpact, Inc
MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Founder Private Equity Investor | |
Stanford University | College/University | Graduate Degree Undergraduate Degree Corporate Officer/Principal | |
ESI GROUP | Packaged Software | Director/Board Member | |
Massachusetts Institute of Technology | College/University | Graduate Degree Doctorate Degree Masters Business Admin | |
Northwestern University
Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Undergraduate Degree | |
University of California, Berkeley | College/University | Doctorate Degree | |
Balboa Insurance Group LLC
Balboa Insurance Group LLC Life/Health InsuranceFinance Balboa Insurance Group, Inc. provides finance and insurance services. The firm offers industry-leading, risk management, and loss mitigation solutions to financial institutions in the mortgage and auto finance industries. Its products include credit life, homeowners insurance, lender placed property hazard insurance, and home warranties. The company is headquartered in Irvine, CA. | Life/Health Insurance | Director of Finance/CFO | |
American Cancer Society, Inc.
American Cancer Society, Inc. Miscellaneous Commercial ServicesCommercial Services American Cancer Society, Inc. provides information on cancer occurrence, survival, prevention, early detection, and treatment. The non-profit company is based in Kennesaw, GA and has subsidiaries in the United States. The company's SHES department is an intramural research program with world-renowned epidemiologists and health scientists. The company was founded in 1913 by Candy Arrington. Karen E. Knudsen has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Director/Board Member | |
QBE Financial Institution Risk Services, Inc.
QBE Financial Institution Risk Services, Inc. Insurance Brokers/ServicesFinance QBE Financial Institution Risk Services, Inc. provides specialty insurance services. It offers mortgage and auto lender-placed protection, voluntary insurance, loss mitigation services, and customized property tax solutions. The company was founded in 1977 and is headquartered in Norcross, GA. | Insurance Brokers/Services | Chief Administrative Officer | |
Baylor College of Medicine | College/University | Doctorate Degree | |
The University of Texas M.D. Anderson Cancer Center
The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services The University of Texas M.D. Anderson Cancer Center provides cancer patient care, research, and prevention for cancer. The firm also provides education for undergraduate and graduate students, trainees, professionals, employees and the publics. The company was founded in 1941 and is headquartered in Houston, TX. | Other Consumer Services | Consultant / Advisor | |
CONSTELLATION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
AH Capital Management LLC
AH Capital Management LLC Investment ManagersFinance AH Capital Management LLC (AH Capital Management) is a venture capital firm founded in 2009 by Marc Lowell Andreessen and Ben A. Horowitz. The firm is headquartered in Menlo Park, California. | Investment Managers | Consultant / Advisor | |
Cristal Delivery BV
Cristal Delivery BV Pharmaceuticals: MajorHealth Technology Cristal Delivery BV develops and manufactures nanomedicines for therapeutic drug optimization. It offers pipeline, oncology, and inflammation programs. The company was founded by Joost J. M. Holthuis and Cristianne Rijcken in April 2011 and is headquartered in Maastricht, the Netherlands. | Pharmaceuticals: Major | Director/Board Member | |
Lumos Pharma Sub, Inc.
Lumos Pharma Sub, Inc. Medical/Nursing ServicesHealth Services Lumos Pharma Sub, Inc. develops and commercializes a novel treatment for the rare disease creatine transporter deficiency. It focuses on bringing novel therapies to patients afflicted with unmet medical needs in severe, rare, and genetic diseases. The firm's technology LUM-001 is a repurposed small molecule that is a kinetically similar analog of creatine and has shown promising therapeutic potential for the treatment of creatine transporter deficiency. Lumos Pharma was founded by Richard J. Hawkins in 2010 and is headquartered in Austin, TX. | Medical/Nursing Services | Director/Board Member | |
Color Health, Inc.
Color Health, Inc. Packaged SoftwareTechnology Services Color Health, Inc. provides genetics services. It offers genetic testing services for hereditary cancers including breast, ovarian, colorectal, pancreatic, uterine, melanoma, prostate, and stomach cancers. The company was founded by Elad Gil, Othman Laraki, Taylor Sittler and Nish Bhat in 2013 and is headquartered in Burlingame, CA. | Packaged Software | Founder | |
Deerfield Management Co. LP (Private Equity)
Deerfield Management Co. LP (Private Equity) Investment ManagersFinance Deerfield Management Co. LP (Private Equity) (Deerfield) is a private equity subsidiary of Deerfield Management Co. LP founded in 1994. The firm is headquartered in the New York. | Investment Managers | Private Equity Investor | |
Blade Therapeutics, Inc.
Blade Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Blade Therapeutics, Inc. offers anti-fibrotic therapies to meet unserved patient needs. Its product portfolio is to address various fibrotic diseases and their underlying pathophysiology. The company was founded by Hal Dietz and Wendye R. Robbins and is headquartered in South San Francisco, CA. | Miscellaneous Commercial Services | Founder Director/Board Member | |
Ribon Therapeutics, Inc.
Ribon Therapeutics, Inc. BiotechnologyHealth Technology Ribon Therapeutics, Inc. operates as a biotechnology company which focuses on developing therapeutics targeting monoADP-ribosylating PARPs for cancer. Its medicines are used for blocking cancer cells? fundamental survival mechanisms. The company was founded by W. Lee Kraus, Tim Mitchison and Paul Chang in 2015 and is headquartered in Lexington, MA. | Biotechnology | Director/Board Member | |
CYTEIR THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
ONCORUS, INC. | Biotechnology | Chairman Director/Board Member | |
MTrap, Inc.
MTrap, Inc. Miscellaneous Commercial ServicesCommercial Services MTrap, Inc. engages in the development of novel therapeutic devices that interfere with the intense dialogue and crosstalk between the primary tumor and the microenvironment and represent a new disruptive approach to cancer treatment. The company was founded by Maybelle L. Jordan and is headquartered in Huntington, NY. | Miscellaneous Commercial Services | Director/Board Member | |
OCTIMET Oncology NV
OCTIMET Oncology NV BiotechnologyHealth Technology OCTIMET Oncology NV develops MET kinase inhibitors for the treatment of cancer. The company was founded by Timothy Perera, Ann Louise Meulemans, Paolo Comoglio, and Philip Owen in 2016 and is headquartered in Beerse, the Netherlands. | Biotechnology | Director/Board Member | |
Highlight Therapeutics SL
Highlight Therapeutics SL Pharmaceuticals: MajorHealth Technology Highlight Therapeutics develops ribonucleic acid-based therapies and novel targets in cancer and immune cells. Its product BO-112, induces immunogenic cell death in solid tumors and simultaneously activates the innate immune system to ensure optimal antigen processing and presentation to the adaptive immune system. The company was founded by Damia tormo Carulla and is headquartered in Paterna, Spain. | Pharmaceuticals: Major | Director/Board Member | |
Pairwise Plants Services
Pairwise Plants Services Food: Major DiversifiedConsumer Non-Durables Pairwise Plants LLC operates as a agriculture company. The company was founded by Feng Zhang, David Liu and J. Keith Joung and is headquartered in Durham, NC. | Food: Major Diversified | Chairman | |
Vibliome Therapeutics LLC
Vibliome Therapeutics LLC BiotechnologyHealth Technology Vibliome Therapeutics LLC develops therapeutics for the treatment of cancer, contraception and other indications. The company was founded by Gary Flynn in 2017 and is headquartered in Bozeman, MT. | Biotechnology | Director/Board Member | |
Mark Foundation
Mark Foundation Miscellaneous Commercial ServicesCommercial Services The Mark Foundation for Cancer Research is a charitable organization that partners with scientists worldwide to accelerate research for the prevention, diagnosis, and treatment of cancer. The Mark Foundation is based in New York, NY and was founded by Alexander Mark Knaster. The foundation has awarded over $200 million in grants to more than 100 academic institutions across 13 countries since 2017. The non-profit company's research programs focus on early career support, team science collaboration, new technology innovation, and therapeutics discovery. The foundation also invests in early-stage cancer diagnostics and therapeutics companies. | Miscellaneous Commercial Services | Consultant / Advisor | |
Black Belt Therapeutics Ltd.
Black Belt Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Black Belt Therapeutics Ltd. is a British biotechnology company. | Miscellaneous Commercial Services | Director/Board Member | |
Civetta Therapeutics LLC
Civetta Therapeutics LLC Pharmaceuticals: MajorHealth Technology Civetta Therapeutics LLC develops therapeutics for cancers and other diseases. The company was founded by William Sellers and Eric Fischer and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chairman | |
Oerth Bio LLC
Oerth Bio LLC BiotechnologyHealth Technology Oerth Bio LLC is an agricultural biotech company that develops sustainable, environmentally-designed crop and farm solutions to reduce the environmental impact of agrochemical solutions and nourish a growing population with eco-friendly, healthy foods. The company is based in Durham, NC. The company was formed as a joint venture between Arvinas and Bayer, supported by over $55 million in committed funding and operational support from Bayer, and technology and intellectual property from Arvinas. Oerth Bio is reimagining crop protection through a comprehensive, therapeutic approach to crop health using Protac® technology, a targeted biotech solution known for its potential in addressing human disease. The CEO of the company is John W. Dombrosky. | Biotechnology | Consultant / Advisor | |
LUMOS PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member | |
NUVALENT, INC. | Biotechnology | Director/Board Member | |
AlivaMab Discovery Services LLC
AlivaMab Discovery Services LLC BiotechnologyHealth Technology AlivaMab Discovery Services LLC is a private company that specializes in generating and screening large panels of antibodies to achieve their partners' design goals. AlivaMab Discovery Services is based in San Diego, CA. The company focuses on delivering antibodies that are characterized for function, kinetics, and developability, and engineering for advanced modalities, including multispecifics and cars. The company has experience in antibody drug discovery and development from many of the world's top pharmaceutical companies, including AbbVie, AstraZeneca, Bristol Myers Squibb, Novartis, Pfizer, and Roche/Genentech. The company was founded by John Lippincott, and the CEO is Larry L. Green. | Biotechnology | Director/Board Member | |
Apertor Pharmaceuticals, Inc.
Apertor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Apertor Pharmaceuticals, Inc. manufactures pharmaceutical products. | Pharmaceuticals: Major | Consultant / Advisor | |
Neomorph, Inc.
Neomorph, Inc. Pharmaceuticals: MajorHealth Technology Neomorph, Inc. is an American venture-backed biotechnology company that focuses on discovering innovative new medicines against 'undruggable' targets to solve critical problems in human health. The company is headquartered in an undisclosed location and has a key collaboration with the Center for Protein Degradation at the Dana Farber Cancer Institute. Neomorph's team is comprised of industry-leading experts in protein degradation and molecular glues who are committed to advancing the science and technology of molecular glue drug discovery. The company's patient-first, science-driven approach is complemented by its dedication to a supportive and collaborative work environment. Neomorph was founded by Eric Fischer, Philip Chamberlain, Scott A. Armstrong, and Benjamin Ebert, with Philip Chamberlain serving as the CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member | |
DF II LP NV
DF II LP NV Financial ConglomeratesFinance DF II LP NV is a private company based in Meise, Belgium. The Belgian company was founded in 2018. | Financial Conglomerates | Director/Board Member | |
Photys Therapeutics, Inc.
Photys Therapeutics, Inc. Medical SpecialtiesHealth Technology Photys Therapeutics, Inc. is a company based in Cambridge, MA that was founded by Longwood Fund and Dr. Amit Choudhary of Brigham and Women's Hospital and the Broad Institute of MIT and Harvard. The company is advancing phosphorylation inducing chimeric small molecules (PHICs), a proprietary new class of bifunctional medicines that direct and repair protein phosphorylation to treat a range of diseases including cancer, immune, metabolic, and rare diseases. PHICs enhance the pairing of specific kinases with disease target proteins, inducing precise phosphorylation at native and/or non-native sites, modulating key functions including activation, stabilization, trafficking, localization, phospho-antigen presentation, inactivation, degradation, and interactions of proteins. The company's approach unlocks diverse classes of targets, developing a new class of medicines for precise control of protein function. The company was founded by Amit Choudhary, David Steinberg, Edward Holson, Lizzie Ngo. David Steinberg has been the CEO since incorporation. | Medical Specialties | Director/Board Member Consultant / Advisor | |
Droia Ventures | Consultant / Advisor | ||
Vicinitas Therapeutics
Vicinitas Therapeutics BiotechnologyHealth Technology Vicinitas Therapeutics is located in the US. Vicinitas Therapeutics is an American US-based biotechnology company that specializes in developing next-generation disease therapies using targeted protein stabilizers called Deubiquituinase Targeting Chimeras (DUBtacs). The company's mission is to solve critical problems in human health by developing disease therapies against an entire class of previously inaccessible disease-causing proteins. | Biotechnology | Founder | |
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal | |
Mixer Labs, Inc.
Mixer Labs, Inc. Packaged SoftwareTechnology Services Part of X Holdings Corp., Mixer Labs, Inc. develops GeoAPI geolocation aware applications software. The company is based in San Mateo, CA. The company was founded by Othman Laraki, Elad Gil. Mixer Labs was acquired by X Corp. (United States) on December 23, 2009. | Packaged Software | Founder |
Statistics
International
United States | 42 |
Belgium | 4 |
France | 2 |
Netherlands | 2 |
China | 2 |
Sectoral
Health Technology | 25 |
Finance | 9 |
Consumer Services | 7 |
Commercial Services | 6 |
Technology Services | 4 |
Operational
Director/Board Member | 78 |
Independent Dir/Board Member | 20 |
Corporate Officer/Principal | 16 |
Founder | 16 |
Consultant / Advisor | 13 |
Most connected contacts
Insiders | |
---|---|
Luke Evnin | 42 |
Cameron Wheeler | 20 |
Pamela Klein | 19 |
Setareh Pouraghabagher | 15 |
Janwillem Naesens | 14 |
Daniel K. Nomura | 12 |
Chris Varma | 9 |
Othman Laraki | 7 |
David M. Goldstein | 6 |
Joan S Brugge | 6 |
- Stock Market
- Insiders
- Roberto Zoncu
- Company connections